Sanara MedTech (SMTI)
(Real Time Quote from BATS)
$27.26 USD
+0.18 (0.67%)
Updated Aug 8, 2024 01:36 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
SMTI 27.26 +0.18(0.67%)
Will SMTI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SMTI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SMTI
Down -14.23% in 4 Weeks, Here's Why Sanara MedTech Inc. (SMTI) Looks Ripe for a Turnaround
What Makes Sanara MedTech Inc. (SMTI) a Good Fit for 'Trend Investing'
SMTI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SMTI
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates
Sanara MedTech Unveils Strategy in Investor Presentation Webcast
Sanara MedTech CEO Steps Down, Agrees to Severance Deal
Sanara MedTech files to sell 255,049 shares of common stock for holders
Sanara MedTech files to sell 255,049 shares of common stock for holders